Brief: Eckert & Ziegler Says EC Approves Eckert & Ziegler's Theralugand

Eckert & Ziegler SE

27/11/2024 08:02

Nov 27 (Reuters) - Eckert & Ziegler SE  EUZG.DE :
    * ECKERT & ZIEGLER SE - EC APPROVES ECKERT & ZIEGLER'S
THERALUGAND
(LUTETIUM-177 CHLORIDE)
    * ECKERT & ZIEGLER - ZIEGLER ACHIEVES EUROPEAN APPROVAL FOR
THERALUGAND® - LUTETIUM-177 CHLORIDE (N.C.A)
    * ECKERT & ZIEGLER SE - THERALUGAND APPROVED FOR CLINICAL
USE IN
EEA
    * ECKERT & ZIEGLER SE - THERALUGAND PROVIDES HIGH-PURITY
LUTETIUM-177 FOR THERAPEUTIC RADIOPHARMACEUTICALS
    * ECKERT & ZIEGLER SE - THERALUGAND TO SUPPORT INNOVATIVE
CANCER
THERAPIES

Source text:  ID:nEQ82K0cXa 
Further company coverage:  EUZG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))